Notable Gainers: Ford Motor Company (NYSE:F), RF Micro Devices, Inc. (NASDAQ:RFMD), Peregrine Pharmaceuticals (NASDAQ:PPHM)

Lakeway, NY -- (SBWIRE) -- 03/12/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Ford Motor Company (NYSE:F) shares climbed 2.77% to $13.34. Ford last week said its China sales grew steadily this month, as year-to-date sales rose 46 percent to 105,209 wholesales sold compared with 71,954 during the same period last year. February sales increased seven percent, with 43,642 wholesale vehicles sold compared with 40,978 in 2012.

Additionally, the company recently expanded its commitment to help encourage the growing community of automotive app developers by announcing it will contribute the software for AppLink, the Ford-developed in-car smartphone app interface, to the GENIVI Alliance. Ford becomes the first American automaker to contribute proprietary source code from one of its products to an open-source project.

Get Latest News, Updates on F Here

RF Micro Devices, Inc. (NASDAQ:RFMD) stock increased 2.62% to $4.70. RFMD’s stock was downgraded by Raymond James to a “market perform” rating in a research note issued on Feb. 21.

Additionally, the company, on Feb. 25, announced the addition of multiple new products to RFMD's industry-leading portfolio of envelope tracking (ET) power management and power amplifier (PA) solutions. RFMD's ET-based solutions leverage the Company's leadership in RF power management and cellular PAs to improve system-level efficiency in high-data rate applications.

Is RFMD a Strong Buying Opportunity After The Recent Gain? Find out Here

Peregrine Pharmaceuticals (NASDAQ:PPHM) shares gained 2.53% to $1.62. The company announced that it will report financial results for the third quarter of the fiscal year (FY) 2013 on March 12, 2013 after market and will host a conference call and webcast at 1:30 PM Pacific Daylight Time (4:30 PM Eastern Daylight Time). Peregrine's senior management will discuss financial results for the third quarter ended January 31, 2013 of FY 2013 and will review recent progress of its clinical development programs.

Additionally, analysts at Piper Jaffray assumed coverage on shares of PPHM in a note issued to investors on Mar. 5. The firm set an “overweight” rating and a $2.50 price target on the stock.

Is PPHM Signaling a Buy After The Sudden Gain? Don’t Miss Out Free Trend Analysis Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.